Vistin Pharma ASA 0RAM.L Stock
24.3 NOK
{{ price }}
1.673639%
{{change_pct}}%
COUNTRY
United Kingdom
Exchange
LSE
Market Cap
0 NOK
LOW - HIGH [24H]
0.0000
-
0.0000 NOK
VOLUME [24H]
540 NOK
{{ volume }}
P/E Ratio
0.43
Earnings per share
0.56 NOK
Vistin Pharma ASA Price Chart
Vistin Pharma ASA 0RAM.L Financial and Trading Overview
| Vistin Pharma ASA stock price | 24.3 NOK |
| Previous Close | 21.05 NOK |
| Open | 0 NOK |
| Bid | 0 NOK x N/A |
| Ask | 0 NOK x N/A |
| Day's Range | 0 - 0 NOK |
| 52 Week Range | 0 - 0 NOK |
| Volume | 0 NOK |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.074712 |
| PE Ratio (TTM) | 0.2547568 |
| EPS (TTM) | 0.56 NOK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0RAM.L Valuation Measures
| Enterprise Value | 656.66M NOK |
| Trailing P/E | 0.2547568 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.3406696 |
| Enterprise Value/Revenue | 1.762 |
| Enterprise Value/EBITDA | 17.434 |
Trading Information
Vistin Pharma ASA Stock Price History
| Beta (5Y Monthly) | 1.074712 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0 NOK |
| 52 Week Low | 0 NOK |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
0RAM.L Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 18.85M |
| Short Ratio | N/A |
| % Held by Insiders | 55.14% |
| % Held by Institutions | 12.08% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.75 |
| Trailing Annual Dividend Yield | 3.56% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 2.00% |
| Operating Margin (ttm) | 6.65% |
| Gross Margin | 55.60% |
| EBITDA Margin | 10.10% |
Management Effectiveness
| Return on Assets (ttm) | 4.40% |
| Return on Equity (ttm) | 2.80% |
Income Statement
| Revenue (ttm) | 372.57M NOK |
| Revenue Per Share (ttm) | 8.4 NOK |
| Quarterly Revenue Growth (yoy) | 203.90% |
| Gross Profit (ttm) | 166.79M NOK |
| EBITDA | 37.67M NOK |
| Net Income Avi to Common (ttm) | 7.46M NOK |
| Diluted EPS (ttm) | 0.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.06M NOK |
| Total Cash Per Share (mrq) | 0.07 NOK |
| Total Debt (mrq) | 27.08M NOK |
| Total Debt/Equity (mrq) | 10.02 NOK |
| Current Ratio (mrq) | 1.401 |
| Book Value Per Share (mrq) | 6.095 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 17.05M NOK |
| Levered Free Cash Flow (ttm) | -33130750 NOK |
Profile of Vistin Pharma ASA
| Country | United Kingdom |
| State | N/A |
| City | Oslo |
| Address | OestensjOeveien 27 |
| ZIP | 0661 |
| Phone | 47 35 98 42 00 |
| Website | https://www.vistin.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 77 |
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Q&A For Vistin Pharma ASA Stock
What is a current 0RAM.L stock price?
Vistin Pharma ASA 0RAM.L stock price today per share is 24.3 NOK.
How to purchase Vistin Pharma ASA stock?
You can buy 0RAM.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vistin Pharma ASA?
The stock symbol or ticker of Vistin Pharma ASA is 0RAM.L.
How many shares does Vistin Pharma ASA have in circulation?
The max supply of Vistin Pharma ASA shares is 0.
What is Vistin Pharma ASA Price to Earnings Ratio (PE Ratio)?
Vistin Pharma ASA PE Ratio is 0.43392855 now.
What was Vistin Pharma ASA earnings per share over the trailing 12 months (TTM)?
Vistin Pharma ASA EPS is 0.56 NOK over the trailing 12 months.